Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Redfern

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|August 1, 2013
Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patientsP A Candy, M R Phillips, A D Redfern, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|May 6, 2019
Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptidesAnabel Sorolla, Edina Wang, Tristan D Clemons, et al.
International Journal of Molecular Sciences|September 14, 2024
BMP4-Induced Suppression of Breast Cancer Metastasis Is Associated with Inhibition of Cholesterol BiosynthesisLap Hing Chi, Andrew D Redfern, Terry C C Lim Kam Sian, et al.
British Journal of Cancer|August 7, 2001
South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's diseaseK J Flavell, J P Biddulph, J E Powell, et al.
Microbial Pathogenesis|February 1, 1996
Lactic acid is the factor in blood cell extracts which enhances the ability of CMP-NANA to sialylate gonococcal lipopolysaccharide and induce serum resistanceN J Parsons, G J Boons, P R Ashton, et al.
Molecular Cancer Therapeutics|September 13, 2013
Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinibKeith M Giles, Felicity C Kalinowski, Patrick A Candy, et al.
BMJ Open|June 1, 2017
Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacyNicolas H Hart, Robert U Newton, Nigel A Spry, et al.
Nature Reviews. Clinical Oncology|July 22, 2025
EMT and cancer: what clinicians should knowErik W Thompson, Andrew D Redfern, Simone Brabletz, et al.
Trials|December 22, 2018
Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicineNicolas H Hart, Daniel A Galvão, Christobel Saunders, et al.
Prostate Cancer and Prostatic Diseases|November 29, 2022
Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancerJin-Soo Kim, Dennis R Taaffe, Daniel A Galvão, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|August 1, 2013
Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patientsP A Candy, M R Phillips, A D Redfern, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|May 6, 2019
Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptidesAnabel Sorolla, Edina Wang, Tristan D Clemons, et al.
International Journal of Molecular Sciences|September 14, 2024
BMP4-Induced Suppression of Breast Cancer Metastasis Is Associated with Inhibition of Cholesterol BiosynthesisLap Hing Chi, Andrew D Redfern, Terry C C Lim Kam Sian, et al.
British Journal of Cancer|August 7, 2001
South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's diseaseK J Flavell, J P Biddulph, J E Powell, et al.
Microbial Pathogenesis|February 1, 1996
Lactic acid is the factor in blood cell extracts which enhances the ability of CMP-NANA to sialylate gonococcal lipopolysaccharide and induce serum resistanceN J Parsons, G J Boons, P R Ashton, et al.
Molecular Cancer Therapeutics|September 13, 2013
Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinibKeith M Giles, Felicity C Kalinowski, Patrick A Candy, et al.
BMJ Open|June 1, 2017
Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacyNicolas H Hart, Robert U Newton, Nigel A Spry, et al.
Nature Reviews. Clinical Oncology|July 22, 2025
EMT and cancer: what clinicians should knowErik W Thompson, Andrew D Redfern, Simone Brabletz, et al.
Trials|December 22, 2018
Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicineNicolas H Hart, Daniel A Galvão, Christobel Saunders, et al.
Prostate Cancer and Prostatic Diseases|November 29, 2022
Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancerJin-Soo Kim, Dennis R Taaffe, Daniel A Galvão, et al.
Pageof 5